Impact of Comorbidities on Response Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with First-Line Dasatinib Versus Imatinib: Exploratory Post Hoc Analysis of DASISION
In: Blood, Jg. 136 (2020-11-05), Heft Supplement 1, S. 31-32
academicJournal
Zugriff:
Titel: |
Impact of Comorbidities on Response Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with First-Line Dasatinib Versus Imatinib: Exploratory Post Hoc Analysis of DASISION
|
---|---|
Autor/in / Beteiligte Person: | Breccia, Massimo ; Mauro, Michael J. ; Jabbour, Elias ; Saglio, Giuseppe ; Jiménez-Velasco, Antonio ; le Coutre, Philipp D ; DeGutis, Irene ; Khan, Wasiulla ; Sy, Oumar ; Swanink, Rene ; Cortes, Jorge E. |
Zeitschrift: | Blood, Jg. 136 (2020-11-05), Heft Supplement 1, S. 31-32 |
Veröffentlichung: | 2020 |
Medientyp: | academicJournal |
ISSN: | 0006-4971 (electronic) |
DOI: | 10.1182/blood-2020-137636 |
Sonstiges: |
|